Covered recipient · General Payments record
DIANE SMITH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$433.68
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $364.20 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $211.15 | 8 |
| ABBVIE INC. | $36.32 | 2 |
| Exact Sciences Corporation | $30.22 | 2 |
| Amgen Inc. | $29.60 | 2 |
| Esperion Therapeutics, Inc. | $21.71 | 1 |
| Janssen Biotech, Inc. | $19.49 | 1 |
| Acerta Pharma LLC | $15.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.00 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108216468 | CMS |
| ABBVIE INC. | $16.32 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108216470 | CMS |
| Amgen Inc. | $15.48 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117687524 | CMS |
| Amgen Inc. | $14.12 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117687526 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.71 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105560194 | CMS |
| Esperion Therapeutics, Inc. | $21.71 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129476528 | CMS |
| Exact Sciences Corporation | $14.63 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114905755 | CMS |
| Exact Sciences Corporation | $15.59 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114905763 | CMS |
| Janssen Biotech, Inc. | $19.49 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078651867 | CMS |
| Novo Nordisk Inc | $19.76 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100448011 | CMS |
| Novo Nordisk Inc | $12.21 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100411500 | CMS |
| Novo Nordisk Inc | $10.62 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100495540 | CMS |
| Novo Nordisk Inc | $14.70 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100325456 | CMS |
| Novo Nordisk Inc | $125.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100349590 | CMS |
| Novo Nordisk Inc | $20.42 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100457262 | CMS |
| Novo Nordisk Inc | $1.77 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100530035 | CMS |
| Novo Nordisk Inc | $6.67 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100607064 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.